home / stock / rlyb / rlyb quote
Last: | $1.20 |
---|---|
Change Percent: | -2.21% |
Open: | $1.39 |
Close: | $1.20 |
High: | $1.42 |
Low: | $1.155 |
Volume: | 714,816 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.2 | $1.39 | $1.2 | $1.42 | $1.155 | 714,816 | 07-02-2024 |
$1.36 | $1.38 | $1.36 | $1.42 | $1.36 | 203,291 | 07-01-2024 |
$1.34 | $1.5 | $1.34 | $1.5 | $1.34 | 3,550,136 | 06-28-2024 |
$1.48 | $1.42 | $1.48 | $1.5 | $1.39 | 230,702 | 06-27-2024 |
$1.4 | $1.49 | $1.4 | $1.53 | $1.4 | 215,823 | 06-26-2024 |
$1.49 | $1.52 | $1.49 | $1.55 | $1.42 | 280,410 | 06-25-2024 |
$1.54 | $1.48 | $1.54 | $1.6 | $1.45 | 177,882 | 06-24-2024 |
$1.46 | $1.43 | $1.46 | $1.5 | $1.43 | 375,522 | 06-21-2024 |
$1.44 | $1.4 | $1.44 | $1.4705 | $1.4 | 161,641 | 06-20-2024 |
$1.4 | $1.45 | $1.4 | $1.475 | $1.395 | 174,318 | 06-19-2024 |
$1.4 | $1.45 | $1.4 | $1.475 | $1.395 | 174,318 | 06-18-2024 |
$1.45 | $1.54 | $1.45 | $1.565 | $1.44 | 198,873 | 06-17-2024 |
$1.545 | $1.62 | $1.545 | $1.66 | $1.48 | 133,564 | 06-14-2024 |
$1.66 | $1.64 | $1.66 | $1.68 | $1.6 | 93,828 | 06-13-2024 |
$1.65 | $1.6 | $1.65 | $1.7291 | $1.6 | 180,950 | 06-12-2024 |
$1.64 | $1.49 | $1.64 | $1.64 | $1.49 | 154,174 | 06-11-2024 |
$1.525 | $1.45 | $1.525 | $1.55 | $1.44 | 148,681 | 06-10-2024 |
$1.48 | $1.52 | $1.48 | $1.54 | $1.46 | 115,165 | 06-07-2024 |
$1.49 | $1.57 | $1.49 | $1.6 | $1.49 | 149,948 | 06-06-2024 |
$1.61 | $1.55 | $1.61 | $1.62 | $1.51 | 137,893 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk for FNAIT Annually and the RLYB212 Addressable Market – ...
- On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 2H 2024 - - $94.2 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2024; Provides Runway into Mid-2026 - Rallybio Corporation (Nasdaq: RLYB), a...